Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased
dramatically in recent years, and pump therapy has been shown to be a safe and effective …

Aims To determine the safety and effectiveness of continuous subcutaneous insulin infusion
(CSII) in attaining long‐term glycaemic control in paediatric patients with Type 1 diabetes …

OBJECTIVE—The efficacy of the insulin analogs now available for multiple daily injection
(MDI) and continuous subcutaneous insulin infusion (CSII) therapy in type 1 diabetes has …

Objectives To investigate in a large population the proportion of daily basal insulin dose
(BD) to daily total insulin dose (TD)(BD/TD) and its association with glycated hemoglobin …

Dosing guidelines for patients with type 1 diabetes using continuous subcutaneous insulin
infusion (CSII), which are historically based on clinical experience and retrospective studies …

Abstract Background/Aims: Continuous subcutaneous insulin infusion (CSII) is a safe and
effective alternative to insulin injections in pediatric type 1 diabetes mellitus. CSII can be …

OBJECTIVE: To assess long-term metabolic outcomes in children with diabetes mellitus that
was diagnosed when they were< 6 years old. STUDY DESIGN: A cohort of 66 children with …

Aims To conduct a multicentre, matched‐pair cohort analysis comparing glycaemic control
and adverse events of continuous subcutaneous insulin infusion (CSII) with multiple daily …

The aim of this study is to determine the proper initial dose adjustment when switching from
multiple daily injections to continuous subcutaneous insulin infusion for type-1 diabetic …

Objective. The purpose of this study was to determine the feasibility of continuous
subcutaneous insulin infusion (CSII)(insulin pump) therapy in routine pediatric diabetes care …